e.l.f. Beauty, Inc. Common Stock (ELF)
Basic Materials › Perfumes, Cosmetics & Other Toilet Preparations
Price History
Feb 9, 2026 — May 21, 2026Investment Snapshot
- Trading 82% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 4/9 — moderate financial health
- ROE of 8.9% — below-average profitability
- Revenue growing at 28% annually
e.l.f. Beauty, Inc. Common Stock (ELF) is a Basic Materials company operating in Perfumes, Cosmetics & Other Toilet Preparations, listed on the NYSE , with a market capitalisation of $3.0 billion . Key value metrics: P/E ratio 28.8, P/B ratio 2.58, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
e.l.f. Beauty, Inc. Common Stock — Fundamental Analysis Summary
e.l.f. Beauty, Inc. Common Stock (ELF) is currently trading 82% above its Graham Number of $27.91, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 28.8x.
On financial health, ELF shows a moderate Piotroski F-Score of 4/9, and modest return on equity of 8.9% (sector average: -1.2%), and manageable leverage with a debt-to-equity ratio of 0.73.
StockPik's composite Value Score for ELF is 67/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ELF reports a high gross margin of 70.3% (sector average: 33.0%) and a solid operating margin of 10.5%.
ELF shows revenue growing at 28% year-over-year, with earnings declining at 12%.